Heartland Advisors Inc Acer Therapeutics Inc. Transaction History

Heartland Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 08, 2019	SELL	$3.45 - $26.86 $759,000 - $5.91 Million	-220,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$16.55 - $30.22 $165,500 - $302,200	10,000 Added 4.76%	220,000 $4.43 Million
Q3 2018 Nov 08, 2018	BUY	$18.0 - $32.83 $1.01 Million - $1.84 Million	56,000 Added 36.36%	210,000 $6.48 Million
Q2 2018 Aug 02, 2018	BUY	$17.71 - $21.6 $1.74 Million - $2.13 Million	98,400 Added 176.98%	154,000 $3.33 Million
Q1 2018 May 10, 2018	BUY	$14.81 - $20.22 $823,436 - $1.12 Million	55,600 New	55,600 $1.07 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Heartland Advisors Inc with notifications on news.